Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
53.46
-2.34 (-4.19%)
Nov 10, 2026, 11:24 AM EST - Market open

Genmab Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Genmab stock has a consensus rating of "Strong Buy" and an average price target of $65.11. The average 1-year stock price forecast is 21.79% higher than the current stock price, while the lowest is $48 (-10.21%) and the highest is $80 (+49.64%).

Price Target: $65.11 (+21.79%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$48$65.11$66.3$80
Change-10.21%+21.79%+24.02%+49.64%

Analyst Ratings

The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy910109109
Buy001111
Hold211112
Sell000000
Strong Sell000000
Total111112111212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 7, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$70
BuyReiterates$70+30.94%Nov 6, 2026
Truist Financial
Truist Financial
Buy
Maintains
$67
BuyMaintains$67+25.33%Nov 6, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
$57
HoldMaintains$57+6.62%Nov 6, 2026
Guggenheim
Guggenheim
Buy
Maintains
$58 → $80
BuyMaintains$58 → $80+49.64%Oct 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.74B
from 3.72B
Increased by 27.36%
Revenue Next Year
5.75B
from 4.74B
Increased by 21.44%
EPS This Year
1.34
from 1.77
Decreased by -24.36%
EPS Next Year
1.83
from 1.34
Increased by 36.68%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Jan 1, 2024Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.29B2.08B2.39B3.12B3.72B4.74B
Revenue Growth
-22.52%61.88%14.68%30.59%19.19%27.36%
Gross Profit
1.29B2.08B2.36B2.98B3.48B4.42B
Gross Margin
100.00%100.00%98.62%95.42%93.60%93.36%
Operating Income
451.68M900.43M772.00M1.02B1.25B1.29B
Net Income
452.29M783.33M631.00M1.13B963.00M838.71M
EPS
----1.771.34
EPS Growth
-----10.69%-24.36%
Forward PE
-----39.88
Free Cash Flow
----1.15B967.56M
No. Analysts
-----17
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.9B
Avg4.7B
Low4.6B

Revenue Growth

Revenue Growth202620272028
High
30.5%
Avg
27.4%
Low
24.8%

EPS Forecast

EPS202620272028
High1.72
Avg1.34
Low1.13

EPS Growth

EPS Growth202620272028
High
-2.9%
Avg
-24.4%
Low
-36.3%